Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
1st EuCornea Congress friday 18 June 09.15 - 11.00 12.00 - 13.30 Cross-Linking Ocular Surface Moderators: L. Mastropasqua ITALY, P. Santoro ITALY Moderators: H.S. Dua UK, E. Midena ITALY 09.15 T. Seiler SWITZERLAND KEYNOTE LECTURE: Cross-linking: from a stabilization of the disease to a long term corneal shape improvement, what can we expect in the future FREE PAPERS (7 Minutes) INVITED SPEAKERS (10 Minutes) 09.25 F. Raiskup GERMANY Cross-linking and thin corneas 09.35 T. Koller switzerland Failure and complication rates of corneal cross linking (CXL) FREE PAPERS (7 Minutes) 09.45 C. Caruso ITALY Evaluation of the penetration through human cornea of riboflavin 0.1% in association with other molecules after transepithelial application 09.52 V. Katsanevaki GREECE PRK and Phakic IOLs 09.59 P. Vinciguerra ITALY Corneal cross-linking for ectasia after excimer laser refractive surgery: One-year results 10.06 J. Ruckhofer AUSTRIA Combination of ICRS and CXL for keratoconus 10.13 I. Paladini ITALY Corneal thickness measurements using Visante, Ultrasound and Pentacam pachymetry before and after corneal cross-linking for keratoconus 10.20 E. Stagni ITALY Trans-epithelial corneal cross linking: 1-year of follow up 10.27 A. Laborante ITALY Corneal cross linking: presentation of clinical cases with special applications 10.34 F. Camesasca ITALY Evaluation of crystalline lens opacity induced by corneal crosslinking with Scheimpflug imaging 10.41 F. Hafezi SWITZERLAND Massive remodeling of the anterior corneal surface following CXL 10.48 F. Majo SWITZERLAND Modified corneal collagen crosslinking (CXL) reduces corneal edema and diurnal visual fluctuations in Fuchsâ dystrophy 14 Sala B Discussion 12.00 R. Mencucci ITALY Autologous serum eyedrops for ocular surface disease treatment: the effect of clotting time on serum growth factor concentrations 12.07 C. Feinbaum SWEDEN The refractive tear film 12.14 P. Aragona ITALY Effects of aminoacids-enriched artificial tears on the ocular surface of patients affected by dysfunctional tear syndrome 12.21 C. Gagliano ITALY Treatment of dysfunctional tear syndrome: role of phytoestrogens 12.28 M. Nubile ITALY In vivo analysis of stromal integration of multilayer amniotic membrane transplantation in corneal ulcers 12.35 M. Frisani ITALY Epithelial, Bowmanâs layer, stroma and pachymetry changes with FD - OCT during orthokeratology 12.42 J.A.P. Gomes BRAZIL Correlation between corneal impression cytology and in vivo confocal microscopy in patients with total limbal stem deficiency 12.49 G. Cusati ITALY Results of corneal calcareous caustication 12.56 D. Dobrowolski POLAND Surgical approach in corneal perforations and deep ulcers 13.03 T. Islam UK Bilateral culture-negative keratitis after laser in situ keratomileusis treated with penetrating keratoplasty and amniotic membrane graft 13.10 V. Profazio ITALY Discomfort symptoms in disposable soft contact lens wearers : efficacy of a two-month treatment with a by-polymer tsp-hyaluronic acid (xiloial) 13.17 S. Morselli ITALY Autoserum treatment with systemic cyclosporine for autoimmune and filamentous keratitis Discussion 13.30 - 15.30 lunch BREAK